Ryner Lai, MBBS

Ryner Lai, MBBS

Dr (MBBS), Queen Mary University, London
Dr Ryner Lai (MBBS) is a medical graduate from Queen Mary, University of London. He is a medical writer who is passionate about the power of medical research to transform the lives of patients.

All articles by Ryner Lai, MBBS

SMA Treatments Valued by Patients and Caregivers

A survey on preferences and utilities for treatment attributes in spinal muscular atrophy (SMA) type 2 and nonambulatory type 3 revealed that both patients and caregivers value motor function, breathing function, and oral administration in the context of treatments, according to a study published in PharmacoEconomics. “Patients with Type 2 SMA are unable to stand…

machine learning

1H-NMR-Based Metabolic Profiling Potentially Valuable in SMA

A team of German researchers has identified 1H-nuclear magnetic resonance (NMR)-based urinary metabolic profiling as a potential diagnostic and prognostic biomarker in spinal muscular atrophy (SMA), according to a study published in the Orphanet Journal of Rare Diseases. One of the major problems hampering the treatment of SMA is that physicians cannot reliably predict disease…

AATD Seems to Worsen the Course of COVID-19 Infection

Epidemiological studies have revealed that patients with alpha-1 antitrypsin deficiency (AATD) have a larger population in geographic areas which report a higher incidence of COVID-19 and mortality, according to a study published in the Journal of Clinical Medicine. The geographical overlap between AATD patients and patients with COVID-19 suggests that there may be an association…

Next post in GIST Insights